SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-003163
Filing Date
2017-03-02
Accepted
2017-03-02 08:00:38
Documents
4
Period of Report
2017-03-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K BOARD MEMBERS ANNOUNCEMENT (MARCH) reta-8k_20161231.htm 8-K 43375
2 EX-10.1 reta-ex101_9.htm EX-10.1 145098
3 EX-99.1_STONE RETIRES MCCLELLAN JOINS REATA BOARD reta-ex991_23.htm EX-99.1 14413
4 GRAPHIC g2017030201411618017012.jpg GRAPHIC 66698
  Complete submission text file 0001564590-17-003163.txt   296120
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 17656961
SIC: 2834 Pharmaceutical Preparations